Free shipping over €250 · Tracked, discreet delivery in Europe
UU library
Every peptide, mapped to the body.
160 compounds, from approved medicines to early research molecules. Each one filed by the system research looks at, with its regulatory status and the strength of the evidence behind it.
- Compounds
- 160
- Research summaries
- 39
- At UU
- 56
- Approved medicine71
Approved as a medicine by the FDA or the EMA for at least one indication. Approval covers the named indication and formulation only.
- In clinical trials19
In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.
- Research compound53
Not approved as a medicine by the FDA or the EMA. Some are registered in individual countries. Supplied for laboratory research only.
- Cosmetic ingredient17
Used as a topical cosmetic ingredient. Cosmetic use is not a medicinal approval, and most evidence comes from manufacturer and small panel studies.
Reviewed October 2026
In the UU catalog
Researched, batch-tested, ready to ship.
Compounds UU carries that have a full research summary in the library.
18 compounds · Muscle, bone & joint
Muscle, bone & joint18
Peptides studied for tendon and muscle repair, bone formation and connective tissue.
- ResearchAt UU
SLU-PP-332
ERR agonist
A small molecule that activates estrogen-related receptors. Studied in mice as an exercise mimetic.
PreclinicalShop - Approved
Abaloparatide
Tymlos · Eladynos
PTHrP analogue
An analogue of parathyroid hormone-related protein. Approved for osteoporosis at high risk of fracture.
Summary pending - Approved
Calcitonin (salmon)
Miacalcin
Calcitonin
A 32-residue hormone from salmon, more potent than the human form. Approved for Paget's disease of bone and hypercalcaemia.
Summary pending - Cosmetic
Carnosine
Beta-alanyl-L-histidine
Dipeptide
A dipeptide concentrated in muscle and brain. Used in skincare and supplements, and studied for glycation and muscle buffering.
Summary pending - Research
Follistatin 344
Myostatin-binding protein
A recombinant form of follistatin, which binds and blocks myostatin. Studied in gene therapy and animal muscle research.
Summary pending - Research
IGF-1 DES
DES(1-3) IGF-I
IGF-1 variant
A naturally occurring truncated IGF-1 with weak binding-protein affinity. Studied in cell and animal research.
Summary pending - Research
Mechano growth factor
MGF · IGF-1Ec
IGF-1 splice variant peptide
A peptide from the E domain of an IGF-1 splice variant produced in loaded muscle. Studied in cell and animal models.
Summary pending - Approved
Palopegteriparatide
Yorvipath
Long-acting PTH(1-34) prodrug
A prodrug that releases PTH(1-34) steadily. Approved for hypoparathyroidism in adults.
Summary pending - Approved
Teriparatide
Forteo · Forsteo
PTH(1-34)
The first 34 residues of parathyroid hormone. Approved for osteoporosis at high risk of fracture.
Summary pending - In trials
Thymosin beta-4
RGN-259
Actin-sequestering peptide
The full 43-residue protein that TB-500 is based on. Studied in clinical trials for dry eye and slow-healing wounds.
Summary pending - Approved
Vosoritide
Voxzogo
C-type natriuretic peptide analogue
A CNP analogue that acts on growth plates. Approved to increase linear growth in children with achondroplasia.
Summary pending - Approved
Zilucoplan
Zilbrysq
Complement C5 inhibitor
A macrocyclic peptide that blocks complement C5. Approved for generalised myasthenia gravis.
Summary pending
The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.